Ponatinix

Sobre este medicamento

Originator: Iclusig by Ariad Pharma · Manufacturer: Beacon pharma. Indication & Dosage: Ponatinix (Ponatinib), generic Iclusig is a prescription medicine used to treat a type of blood cancer which is chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) for whom no other tyrosine kinase inhibitor (TKI) medicines are received. Ponatinix manufactured by Beacon Pharma Ltd. in Bangladesh. Ponatinib has to take 45mg orally once a day with or without food. Side Effects: The most common adverse reactions of Ponatinib are: Headache , dizziness , constipation , or loss of appetite. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.